{"title":"20世纪90年代的临床微生物学:新兴病原体和氟喹诺酮类药物的作用","authors":"Charles W. Stratton MD","doi":"10.1016/0278-2316(92)90040-K","DOIUrl":null,"url":null,"abstract":"<div><p>Clearly, the fluoroquinolones have great potential for becoming as useful a class of antimicrobial agents as the β-lactams. In particular, their use in difficult-to-treat infections as discussed above is likely to be of tremendous importance. As the 1990s progress, additional in vitro and in vivo data will become available. This information should ultimately confirm or deny the clinical usefulness of this exciting new class of antibiotics.</p></div>","PeriodicalId":92907,"journal":{"name":"Infectious diseases newsletter (New York, N.Y.)","volume":"11 4","pages":"Pages 25-29"},"PeriodicalIF":0.0000,"publicationDate":"1992-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0278-2316(92)90040-K","citationCount":"1","resultStr":"{\"title\":\"Clinical microbiology in the 1990s: Emerging pathogens and the role of the fluoroquinolones\",\"authors\":\"Charles W. Stratton MD\",\"doi\":\"10.1016/0278-2316(92)90040-K\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Clearly, the fluoroquinolones have great potential for becoming as useful a class of antimicrobial agents as the β-lactams. In particular, their use in difficult-to-treat infections as discussed above is likely to be of tremendous importance. As the 1990s progress, additional in vitro and in vivo data will become available. This information should ultimately confirm or deny the clinical usefulness of this exciting new class of antibiotics.</p></div>\",\"PeriodicalId\":92907,\"journal\":{\"name\":\"Infectious diseases newsletter (New York, N.Y.)\",\"volume\":\"11 4\",\"pages\":\"Pages 25-29\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1992-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0278-2316(92)90040-K\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infectious diseases newsletter (New York, N.Y.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/027823169290040K\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious diseases newsletter (New York, N.Y.)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/027823169290040K","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Clinical microbiology in the 1990s: Emerging pathogens and the role of the fluoroquinolones
Clearly, the fluoroquinolones have great potential for becoming as useful a class of antimicrobial agents as the β-lactams. In particular, their use in difficult-to-treat infections as discussed above is likely to be of tremendous importance. As the 1990s progress, additional in vitro and in vivo data will become available. This information should ultimately confirm or deny the clinical usefulness of this exciting new class of antibiotics.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
